McKesson Europe Liabilities 2025

McKesson Europe Aktienanalyse

What does McKesson Europe do?

The McKesson Europe AG is one of the largest pharmacy and pharmaceutical trading chains in Europe and has its roots in the USA. The company was founded in 1833 by John McKesson in New York City and initially focused on the sale of medical equipment and drugs for hospitals. Since then, the company has continuously evolved and expanded. In 2007, the company merged with the German Celesio AG and subsequently operated under the name McKesson Europe AG. The company now operates with over 1,500 pharmacies in more than 15 countries and employs over 39,000 people worldwide. The business model of McKesson Europe AG focuses on the distribution of medications and health and beauty products. The company's strategy is to offer a wide range of products and services to pharmacies, consumers, and clinics. The company is divided into various business segments. Prominent examples of these business segments are wholesale and pharmaceutical manufacturing, as well as involvement in online retail, consulting services for pharmacists and clinics, and the company is also an Apple OEP contractor. The wholesale division of McKesson Europe AG is one of the largest in Europe and supplies pharmacies, clinics, and specialized retailers throughout Europe. The company relies on efficient logistics to ensure fast and smooth delivery of ordered goods. Another key area in which McKesson Europe AG operates is pharmaceutical manufacturing. The company produces medications for patients and clinics. In addition, the company is also active in the online industry and operates various online shops for medications and beauty products. The company emphasizes high product quality and fast shipping. In the field of consulting and training, McKesson Europe AG supports pharmacies and clinics in optimizing their business processes and provides assistance in patient care and improving medical services. The portfolio of McKesson Europe AG is accordingly diverse and ranges from prescription and non-prescription medications to healthcare and beauty products, as well as medical devices and aids. Overall, McKesson Europe AG is a company with a long history and a wide portfolio of products and services that relies on efficient logistics and high quality and customer satisfaction. McKesson Europe ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing McKesson Europe's Liabilities

McKesson Europe's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating McKesson Europe's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing McKesson Europe's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

McKesson Europe's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in McKesson Europe’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about McKesson Europe stock

What is the level of liabilities of McKesson Europe this year?

McKesson Europe has a debt balance of 2.61 B EUR this year.

What were the liabilities of McKesson Europe compared to the previous year?

The liabilities of McKesson Europe have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of McKesson Europe?

High liabilities can pose a risk for investors of McKesson Europe, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in McKesson Europe?

Low liabilities mean that McKesson Europe has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of McKesson Europe affect the company?

An increase in liabilities of McKesson Europe can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of McKesson Europe affect the company?

A decrease in the liabilities of McKesson Europe can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of McKesson Europe?

Some factors that can influence the liabilities of McKesson Europe include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of McKesson Europe so important for investors?

The liabilities of McKesson Europe are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can McKesson Europe take to modify the liabilities?

To change its liabilities, McKesson Europe can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does McKesson Europe pay?

Over the past 12 months, McKesson Europe paid a dividend of 0.83 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, McKesson Europe is expected to pay a dividend of 0.83 EUR.

What is the dividend yield of McKesson Europe?

The current dividend yield of McKesson Europe is 3.4 %.

When does McKesson Europe pay dividends?

McKesson Europe pays a quarterly dividend. This is distributed in the months of September, December, December, September.

How secure is the dividend of McKesson Europe?

McKesson Europe paid dividends every year for the past 20 years.

What is the dividend of McKesson Europe?

For the upcoming 12 months, dividends amounting to 0.83 EUR are expected. This corresponds to a dividend yield of 3.4 %.

In which sector is McKesson Europe located?

McKesson Europe is assigned to the 'Health' sector.

Wann musste ich die Aktien von McKesson Europe kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of McKesson Europe from 8/1/2022 amounting to 0.83 EUR, you needed to have the stock in your portfolio before the ex-date on 8/1/2022.

When did McKesson Europe pay the last dividend?

The last dividend was paid out on 8/1/2022.

What was the dividend of McKesson Europe in the year 2024?

In the year 2024, McKesson Europe distributed 0.83 EUR as dividends.

In which currency does McKesson Europe pay out the dividend?

The dividends of McKesson Europe are distributed in EUR.